The Journal of Bone and Joint Surgery (American) 83:1524-1528 (2001)
© 2001 The Journal of Bone and Joint Surgery, Inc.
Thirty-Day Mortality After Elective Total Hip Arthroplasty
Javad Parvizi, MD, FRCS,
Blake G. Johnson, MD,
Charles Rowland, MS,
Mark H. Ereth, MD and
David G. Lewallen, MD
Investigation performed at the Departments of Orthopedics and
Anesthesiology and the Section of Biostatistics, Mayo Clinic and
Mayo Foundation, Rochester, Minnesota
Javad Parvizi, MD, FRCS
Blake G. Johnson, MD
Charles Rowland, MS
Mark H. Ereth, MD
David G. Lewallen, MD
Departments of Orthopedics (J.P., B.G.J., and D.G.L.) and Anesthesiology
(M.H.E.) and Section of Biostatistics (C.R.), Mayo Clinic and Mayo
Foundation, 200 First Street S.W., Rochester, MN 55905. E-mail address
for D.G. Lewallen: lewallen.david{at}mayo.edu
No benefits in any form have been received or will be received from
a commercial party related directly or indirectly to the subject
of this article. No funds were received in support of this study.
Background: Previous reports on perioperative
mortality associated with hip arthroplasty have not documented,
to our knowledge, patient characteristics and surgical factors that
increase the likelihood of death. The purpose of this study was
to determine the prevalence of and associated risk factors for perioperative
death after elective hip arthroplasty.
Methods: The records of 30,714 consecutive patients
who had undergone elective hip arthroplasty at our institution from
1969 to 1997 were retrospectively reviewed to identify patients
who had died within thirty days after the procedure. Mortality rates were
determined according to age, gender, diagnosis, implant type, and
fixation mode.
Results: Ninety deaths occurred within thirty days
after elective total hip arthroplasty, for an overall mortality
rate of 0.29% (ninety of 30,714). The thirty-day mortality
rate was significantly higher for patients with preexisting cardiovascular
disease (p < 0.0001), male patients (p < 0.0001),
and patients who were seventy years of age or older (p < 0.0002).
The mortality rate was slightly, but not significantly, higher for
patients with an underlying diagnosis of rheumatoid arthritis (p < 0.36)
and those receiving cemented implants (p < 0.57). There
was no difference in the thirty-day mortality rate for revision
as compared with primary hip arthroplasty (p < 0.92).
Conclusions: Factors that are associated with an
increased risk of mortality within thirty days after elective hip
arthroplasty include an older age, male gender, and a history of
cardiorespiratory disease. There has been a significant decline
in the thirty-day mortality rate after elective hip arthroplasty
in the last decade (p < 0.0002); during the 1990s, the
overall rate at our institution was 0.15% (twenty-three
of 14,989).

CiteULike Connotea Del.icio.us Facebook Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Sanchez-Sotelo, J. W. Sperling, and B. F. Morrey
Ninety-Day Mortality After Total Elbow Arthroplasty
J. Bone Joint Surg. Am.,
July 1, 2007;
89(7):
1449 - 1451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Parvizi, A. Mui, J. J. Purtill, P. F. Sharkey, W. J. Hozack, and R. H. Rothman
Total Joint Arthroplasty: When Do Fatal or Near-Fatal Complications Occur?
J. Bone Joint Surg. Am.,
January 1, 2007;
89(1):
27 - 32.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Bozic, S. Morshed, M. D. Silverstein, H. E. Rubash, and J. G. Kahn
Use of Cost-Effectiveness Analysis to Evaluate New Technologies in Orthopaedics. The Case of Alternative Bearing Surfaces in Total Hip Arthroplasty
J. Bone Joint Surg. Am.,
April 1, 2006;
88(4):
706 - 714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Moriyama, S. Watanabe, T. Hiraki, T. Kano, T. Okawa, and M. Ishibashi
Relationship between intraoperative transoesophageal echocardiography findings and perfusion lung scintigraphy results on first postoperative day
Br. J. Anaesth.,
May 1, 2005;
94(5):
607 - 612.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Moran, D. G. Lewallen, M. H. Ereth, and J. Parvizi
Thirty-Day Mortality Following Hip Arthroplasty * D.G. Lewallen, M.H. Ereth, and J. Parvizi reply:
J. Bone Joint Surg. Am.,
March 1, 2005;
87(3):
680 - 680.
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Parvizi, M. H. Ereth, and D. G. Lewallen
Thirty-Day Mortality Following Hip Arthroplasty for Acute Fracture
J. Bone Joint Surg. Am.,
September 1, 2004;
86(9):
1983 - 1988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Huddleston, K. H. Long, J. M. Naessens, D. Vanness, D. Larson, R. Trousdale, M. Plevak, M. Cabanela, D. Ilstrup, R. M. Wachter, et al.
Medical and Surgical Comanagement after Elective Hip and Knee Arthroplasty: A Randomized, Controlled Trial
Ann Intern Med,
July 6, 2004;
141(1):
28 - 38.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Huo
What's New in Hip Arthroplasty
J. Bone Joint Surg. Am.,
October 10, 2002;
84(10):
1894 - 1905.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Bhattacharyya, R. Iorio, and W. L. Healy
Rate of and Risk Factors for Acute Inpatient Mortality After Orthopaedic Surgery
J. Bone Joint Surg. Am.,
April 1, 2002;
84(4):
562 - 572.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|